The selective inhibition of IKKα presents a significant therapeutic advantage, particularly in avoiding the adverse effects and toxicity associated with IKKβ inhibition, such as inflammatory skin diseases and increased epithelial vulnerability. This evidence concerns the gene CHUK and inflammatory skin disease.